vs
National Bank Holdings Corp（NBHC）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
REPLIGEN CORP的季度营收约是National Bank Holdings Corp的1.6倍（$197.9M vs $126.8M），National Bank Holdings Corp净利率更高（16.4% vs 6.7%，领先9.7%），过去两年REPLIGEN CORP的营收复合增速更高（14.4% vs 14.0%）
这是一家美国区域性银行控股集团，目前在伊利诺伊、印第安纳等八个美国州布局营业网点，拥有近250个金融服务中心与约200家零售分行，总资产达485亿美元。它是总部位于印第安纳州的最大银行控股公司，也跻身美国银行业三十强之列。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
NBHC vs RGEN — 直观对比
营收规模更大
RGEN
是对方的1.6倍
$126.8M
净利率更高
NBHC
高出9.7%
6.7%
两年增速更快
RGEN
近两年复合增速
14.0%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $126.8M | $197.9M |
| 净利润 | $20.8M | $13.3M |
| 毛利率 | — | 52.5% |
| 营业利润率 | — | 9.0% |
| 净利率 | 16.4% | 6.7% |
| 营收同比 | — | 13.6% |
| 净利润同比 | -14.2% | 143.9% |
| 每股收益（稀释后） | $0.46 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NBHCRGEN
| Q1 26 | $126.8M | — | ||
| Q4 25 | $100.6M | $197.9M | ||
| Q3 25 | $108.9M | $188.8M | ||
| Q2 25 | $104.5M | $182.4M | ||
| Q1 25 | $102.1M | $169.2M | ||
| Q4 24 | $101.3M | $174.1M | ||
| Q3 24 | $106.0M | $154.9M | ||
| Q2 24 | $97.6M | $154.1M |
净利润NBHCRGEN
| Q1 26 | $20.8M | — | ||
| Q4 25 | $16.0M | $13.3M | ||
| Q3 25 | $35.3M | $14.9M | ||
| Q2 25 | $34.0M | $14.9M | ||
| Q1 25 | $24.2M | $5.8M | ||
| Q4 24 | $28.2M | $-30.3M | ||
| Q3 24 | $33.1M | $-654.0K | ||
| Q2 24 | $26.1M | $3.3M |
毛利率NBHCRGEN
| Q1 26 | — | — | ||
| Q4 25 | — | 52.5% | ||
| Q3 25 | — | 53.2% | ||
| Q2 25 | — | 50.0% | ||
| Q1 25 | — | 53.6% | ||
| Q4 24 | — | 26.1% | ||
| Q3 24 | — | 50.0% | ||
| Q2 24 | — | 49.8% |
营业利润率NBHCRGEN
| Q1 26 | — | — | ||
| Q4 25 | 19.0% | 9.0% | ||
| Q3 25 | 39.6% | 8.9% | ||
| Q2 25 | 39.8% | 7.6% | ||
| Q1 25 | 29.2% | 3.9% | ||
| Q4 24 | 34.3% | -17.7% | ||
| Q3 24 | 37.6% | -5.1% | ||
| Q2 24 | 32.5% | 1.0% |
净利率NBHCRGEN
| Q1 26 | 16.4% | — | ||
| Q4 25 | 15.9% | 6.7% | ||
| Q3 25 | 32.4% | 7.9% | ||
| Q2 25 | 32.6% | 8.2% | ||
| Q1 25 | 23.7% | 3.4% | ||
| Q4 24 | 27.8% | -17.4% | ||
| Q3 24 | 31.2% | -0.4% | ||
| Q2 24 | 26.8% | 2.2% |
每股收益（稀释后）NBHCRGEN
| Q1 26 | $0.46 | — | ||
| Q4 25 | $0.42 | $0.24 | ||
| Q3 25 | $0.92 | $0.26 | ||
| Q2 25 | $0.88 | $0.26 | ||
| Q1 25 | $0.63 | $0.10 | ||
| Q4 24 | $0.72 | $-0.55 | ||
| Q3 24 | $0.86 | $-0.01 | ||
| Q2 24 | $0.68 | $0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $472.8M | $767.6M |
| 总债务越低越好 | $202.1M | $542.2M |
| 股东权益账面价值 | $1.7B | $2.1B |
| 总资产 | $12.6B | $2.9B |
| 负债/权益比越低杠杆越低 | 0.12× | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资NBHCRGEN
| Q1 26 | $472.8M | — | ||
| Q4 25 | $417.1M | $767.6M | ||
| Q3 25 | $555.6M | $748.7M | ||
| Q2 25 | $296.5M | $708.9M | ||
| Q1 25 | $246.3M | $697.2M | ||
| Q4 24 | $127.8M | $757.4M | ||
| Q3 24 | $180.8M | $784.0M | ||
| Q2 24 | $145.0M | $809.1M |
总债务NBHCRGEN
| Q1 26 | $202.1M | — | ||
| Q4 25 | $54.5M | $542.2M | ||
| Q3 25 | $54.7M | $537.9M | ||
| Q2 25 | $54.4M | — | ||
| Q1 25 | $54.6M | — | ||
| Q4 24 | $54.5M | $525.6M | ||
| Q3 24 | $54.4M | — | ||
| Q2 24 | $54.4M | — |
股东权益NBHCRGEN
| Q1 26 | $1.7B | — | ||
| Q4 25 | $1.4B | $2.1B | ||
| Q3 25 | $1.4B | $2.1B | ||
| Q2 25 | $1.4B | $2.1B | ||
| Q1 25 | $1.3B | $2.0B | ||
| Q4 24 | $1.3B | $2.0B | ||
| Q3 24 | $1.3B | $2.0B | ||
| Q2 24 | $1.2B | $2.0B |
总资产NBHCRGEN
| Q1 26 | $12.6B | — | ||
| Q4 25 | $9.9B | $2.9B | ||
| Q3 25 | $10.2B | $2.9B | ||
| Q2 25 | $10.0B | $2.9B | ||
| Q1 25 | $10.1B | $2.9B | ||
| Q4 24 | $9.8B | $2.8B | ||
| Q3 24 | $10.0B | $2.8B | ||
| Q2 24 | $10.0B | $2.9B |
负债/权益比NBHCRGEN
| Q1 26 | 0.12× | — | ||
| Q4 25 | 0.04× | 0.26× | ||
| Q3 25 | 0.04× | 0.26× | ||
| Q2 25 | 0.04× | — | ||
| Q1 25 | 0.04× | — | ||
| Q4 24 | 0.04× | 0.27× | ||
| Q3 24 | 0.04× | — | ||
| Q2 24 | 0.04× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $25.7M |
| 自由现金流经营现金流 - 资本支出 | — | $17.6M |
| 自由现金流率自由现金流/营收 | — | 8.9% |
| 资本支出强度资本支出/营收 | — | 4.1% |
| 现金转化率经营现金流/净利润 | — | 1.93× |
| 过去12个月自由现金流最近4个季度 | — | $93.9M |
8季度趋势，按日历期对齐
经营现金流NBHCRGEN
| Q1 26 | — | — | ||
| Q4 25 | $162.4M | $25.7M | ||
| Q3 25 | $52.4M | $48.1M | ||
| Q2 25 | $32.3M | $28.6M | ||
| Q1 25 | $39.6M | $15.0M | ||
| Q4 24 | $155.3M | $39.2M | ||
| Q3 24 | $47.0M | $49.3M | ||
| Q2 24 | $31.9M | $42.2M |
自由现金流NBHCRGEN
| Q1 26 | — | — | ||
| Q4 25 | — | $17.6M | ||
| Q3 25 | — | $43.4M | ||
| Q2 25 | — | $21.5M | ||
| Q1 25 | — | $11.4M | ||
| Q4 24 | — | $33.6M | ||
| Q3 24 | — | $42.3M | ||
| Q2 24 | — | $37.4M |
自由现金流率NBHCRGEN
| Q1 26 | — | — | ||
| Q4 25 | — | 8.9% | ||
| Q3 25 | — | 23.0% | ||
| Q2 25 | — | 11.8% | ||
| Q1 25 | — | 6.8% | ||
| Q4 24 | — | 19.3% | ||
| Q3 24 | — | 27.3% | ||
| Q2 24 | — | 24.3% |
资本支出强度NBHCRGEN
| Q1 26 | — | — | ||
| Q4 25 | — | 4.1% | ||
| Q3 25 | — | 2.5% | ||
| Q2 25 | — | 3.9% | ||
| Q1 25 | — | 2.1% | ||
| Q4 24 | — | 3.2% | ||
| Q3 24 | — | 4.5% | ||
| Q2 24 | — | 3.1% |
现金转化率NBHCRGEN
| Q1 26 | — | — | ||
| Q4 25 | 10.13× | 1.93× | ||
| Q3 25 | 1.48× | 3.23× | ||
| Q2 25 | 0.95× | 1.92× | ||
| Q1 25 | 1.64× | 2.57× | ||
| Q4 24 | 5.51× | — | ||
| Q3 24 | 1.42× | — | ||
| Q2 24 | 1.22× | 12.70× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NBHC
| Net Interest Income | $108.8M | 86% |
| Noninterest Income | $18.0M | 14% |
RGEN
暂无分部数据
